CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’

Positive
AI Analysis

Summary

ai3Bio, formed from two biotechs, is developing autoimmune therapies that target T helper cells rather than B cells, representing a different approach to immune reset treatment.

Importance:2/10
Sentiment:
0.30
AutoimmuneImmunologyT_helper_cellsDrug_mechanism
Related Companies

Read the original article

Published by BioPharma Dive on September 29, 2026 1:00 PM

Read Original